Literature DB >> 15951669

Mathematical models of ovarian cancer incidence.

Bernard A Rosner1, Graham A Colditz, Penny M Webb, Susan E Hankinson.   

Abstract

BACKGROUND: Pike has proposed "protected time" as one summary method for modeling reproductive risk factors in relation to ovarian cancer incidence. We evaluate this and other approaches to summarizing risk for ovarian cancer.
METHODS: We identified 472 incident cases of ovarian cancer during 2,298,068 person-years of follow-up of 24- to 55-year-old premenopausal women at cohort inception. Reproductive exposures, use of oral contraceptives, and history of tubal ligation were evaluated.
RESULTS: Age at menopause is directly related to cumulative risk of ovarian cancer up to age 70 years (age 55 vs. age 45, risk increase = 62%; 95% confidence interval = 36 to 96%) and age at menarche is inversely related to risk (age 15 vs. 11, risk reduction = 31%; 27-34%). Use of oral contraceptives for 5 years before age 30 decreases risk of ovarian cancer to age 70 by 37% (32 to 41%). Tubal ligation reduces risk up to age 70 by 21% (-2 to 38%). Parity reduces risk, independent of age at first birth and age at last birth. A model summarizing years of ovulation offers a fit comparable to a more complex modeling of reproductive variables. The model fit is good, with a concordance statistic of 0.60 (0.57 to 0.62) indicating reasonable ability to differentiate those who will develop ovarian cancer from those who will remain disease free.
CONCLUSION: This model may be applied in the identification of women at high risk for ovarian cancer, for example, in selecting candidates for prevention trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951669     DOI: 10.1097/01.ede.0000164557.81694.63

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  19 in total

1.  Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.

Authors:  Simone P Pinheiro; Susan E Hankinson; Shelley S Tworoger; Bernard A Rosner; John R McKolanis; Olivera J Finn; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Criteria for the evaluation of large cohort studies: an application to the nurses' health study.

Authors:  Graham A Colditz; Deborah M Winn
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

3.  Timing of births and endometrial cancer risk in Swedish women.

Authors:  Ruth M Pfeiffer; Aya Mitani; Ola Landgren; Anders Ekbom; Sigurdur Y Kristinsson; Magnus Björkholm; Robert J Biggar; Louise A Brinton
Journal:  Cancer Causes Control       Date:  2009-06-30       Impact factor: 2.506

4.  Using multiple risk models with preventive interventions.

Authors:  Mitchell H Gail
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

5.  Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Authors:  Kana Wu; Edward L Giovannucci; Yin Cao; Bernard A Rosner; Jing Ma; Rulla M Tamimi; Andrew T Chan; Charles S Fuchs
Journal:  Int J Cancer       Date:  2015-04-23       Impact factor: 7.396

6.  Age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer.

Authors:  Bernard Rosner; Graham A Colditz
Journal:  Ann Epidemiol       Date:  2011-03-26       Impact factor: 3.797

7.  Epidemiologic paradigms for progress in ovarian cancer research.

Authors:  Shelley S Tworoger; Jennifer Anne Doherty
Journal:  Cancer Causes Control       Date:  2017-05       Impact factor: 2.506

Review 8.  Risk assessment models to estimate cancer probabilities.

Authors:  Constance M Johnson; Derek Smolenski
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

9.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Authors:  Merlise A Clyde; Rachel Palmieri Weber; Edwin S Iversen; Elizabeth M Poole; Jennifer A Doherty; Marc T Goodman; Roberta B Ness; Harvey A Risch; Mary Anne Rossing; Kathryn L Terry; Nicolas Wentzensen; Alice S Whittemore; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Michael E Carney; Daniel W Cramer; Julie M Cunningham; Kara L Cushing-Haugen; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Galina Lurie; Valerie McGuire; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Joseph H Rothstein; Thomas A Sellers; Weiva Sieh; Daniel Stram; Pamela J Thompson; Robert A Vierkant; Kristine G Wicklund; Anna H Wu; Argyrios Ziogas; Shelley S Tworoger; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-10-03       Impact factor: 4.897

10.  Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.

Authors:  Yikyung Park; Andrew Nathan Freedman; Mitchell H Gail; David Pee; Albert Hollenbeck; Arthur Schatzkin; Ruth M Pfeiffer
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.